The Patent Finder

KCL Therapeutics, Inc.

Also on record
Records under this name other than the patents KCL Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.

Showing 1 to 3 of 3 · Back to KCL Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,088,485Methods of Screening Compounds That Can Modulate NR2F6 by Displacement of a Reference Ligand
Lapsed on the fee record
Ended Oct 2, 2026 · High confidence
Lapsed on the fee recordEnded Oct 2, 2026High confidence
US 11,377,442Small Molecule Agonists and Antagonists of NR2F6 Activity
Formerly held
Lapsed on the fee record
Ended Jul 5, 2026 · High confidence
Lapsed on the fee recordEnded Jul 5, 2026High confidence
US 11,324,719Small Molecule Agonists and Antagonists of NR2F6 Activity in Humans
Lapsed on the fee record
Ended May 10, 2026 · High confidence
Lapsed on the fee recordEnded May 10, 2026High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited